GSK Investigational Site

Salerno 84131

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Rhinitis, Allergic, Perennial

Studies at this site

• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype — Completed
• Perennial Allergic Rhinitis Study In Pediatric Subjects — Completed